+ +

•  

   

     Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);    

  
  

•  

   

     Flow cytometric analysis of Jurkat cells using PPARA mouse mAb (green) and negative control (red).    

  
  

The peroxisome proliferator-activated receptor alpha (PPARA) is a nuclear receptor transcription factor that plays a central role in regulating lipid metabolism, fatty acid β-oxidation, and glucose homeostasis. It is highly expressed in tissues with high energy demands, such as the liver, heart, and skeletal muscle. PPARA activates target genes by binding to specific DNA response elements as a heterodimer with the retinoid X receptor (RXR), responding to endogenous ligands like fatty acids and synthetic agonists such as fibrates. Its involvement in metabolic pathways makes it a key focus in studying obesity, diabetes, atherosclerosis, and non-alcoholic fatty liver disease (NAFLD).

PPARA antibodies are essential tools for detecting and quantifying PPARA protein expression, localization, and activity in both physiological and pathological contexts. These antibodies are widely used in techniques like Western blotting, immunohistochemistry (IHC), immunofluorescence (IF), and chromatin immunoprecipitation (ChIP). High-quality PPARA antibodies exhibit specificity for distinct isoforms or post-translationally modified forms, enabling precise analysis in disease models or drug-response studies. Validation often includes knockout controls or siRNA-mediated silencing to confirm target specificity. Research utilizing PPARA antibodies has advanced understanding of its regulatory roles in metabolic disorders and its potential as a therapeutic target, particularly in lipid-lowering therapies. Commercial availability of these antibodies from multiple suppliers supports their broad application in basic and translational research.